Bitcoin

The $2B valuation reflects the broader AI boom, which historically has spilled over into AI-focused crypto tokens (e.g., FET, AGIX, RNDR). However, this is a traditional startup, not a token project, so the spillover is indirect and weak. Meanwhile, the macro environment remains bearish with high BTC dominance, suggesting capital is rotating into BTC rather than altcoins.

OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup with a valuation of $2 billion.

OpenAI Researcher Miles Wang in Talks to Launch $2B AI Drug Discovery Startup

The $2B valuation of an AI drug discovery startup signals a capital rotation from crypto to AI, deepening the crypto bear market.